A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB

Using the best available evidence and expert consensus, this document provides guidance for adverse effect monitoring in multidrug-resistant TB (MDR-TB). It includes recommendations for baseline tests, routine drug and toxicity monitoring guides as well as individual drug monographs for all drugs cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Potter, J L, Capstick, T, Ricketts, W M, Whitehead, N, Kon, O M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Chest Clinic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345768/
https://www.ncbi.nlm.nih.gov/pubmed/24928813
http://dx.doi.org/10.1136/thoraxjnl-2014-205278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345768/
https://www.ncbi.nlm.nih.gov/pubmed/24928813
http://dx.doi.org/10.1136/thoraxjnl-2014-205278

Ejemplares similares